Clinical trial
OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for…
NCT00112086 · Japan Clinical Oncology Group, Other · Completed
Key facts
| NCT number | NCT00112086 |
|---|---|
| Title | OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206 |
| Official title | Feasibility Study of Neoadjuvant Chemotherapy Followed by Interval Cytoreductive Surgery for Stage III/IV Ovarian, Tubal and Peritoneal Cancers: JCOG0206 |
| Lead sponsor | Japan Clinical Oncology Group, Other |
| Collaborators | Ministry of Health, Labour and Welfare, Japan |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms |
| Intervention type | Drug |
| Interventions | Neoadjuvant chemotherapy (Paclitaxel and Carboplatin) |
| Enrollment | 56 |
| Start date | Jan 1, 2003 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | May 30, 2005 |
| Last update posted | Aug 31, 2016 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: